NCODA Patient Surveys Support the Need for Medically Integrated Pharmacies

Kirollos Hanna, PharmD, BCPS, BCOP
NCODA Executive Council

Oral Oncolytics, or oral chemotherapies, have significantly impacted the treatment of cancer. They enable patients to conveniently manage treatment in their homes. Despite the rapid growth, therapeutic advances, novel mechanisms of actions, and improved outcomes associated with these agents, the dispensing process remains inadequate. As a result of rising drug costs and healthcare expenditures, payers have forced a “medically disintegrated” model of dispensing…

Patient Satisfaction Surveys: A Continuous NCODA Initiative for Improvement Within the Oncology Dispensing Practice

Joshua Nubla, PharmD
Robert Orzechowski, MBA
Aaron Budge, PharmD

Patient Satisfaction is an essential metric in the growing trend of value-based care within the oncology community. The National Community Oncology Dispensing Association (NCODA), in conjunction with Syracuse University’s Maxwell School of Citizenship and Public Affairs’ Community Link Program, has developed and distributed a patient satisfaction survey to its practice members…

Financial Impact from In-Office Dispensing of Oral Chemotherapy

Anna Howard, PharmD
Julia Kerr, PharmD
Monica McLain, PharmD
Jessie Modlin, PharmD

Oral chemotherapy agents are being prescribed more frequently in many cancer types. In-office dispensing of oral chemotherapy agents has demonstrated clinical benefits and also shown financial benefits to third-party payers…

The Role of the Oral Oncology Nurse Navigator: Oral Oncology Nurse Navigators Improve Patient Care & Satisfaction

Mary Anderson, BSN, RN, OCN
Michael Reff, RPh, MBA
Rebecca McMahon, MHA, BSN, RN, OCN
Deborah Walters, RN, OCN

Patients prescribed oral chemotherapies must understand that while taking an oral medication may offer flexibility with regards to when and where patients take their medications, it does not exempt them from the toxicities normally associated with IV chemotherapy…

Positive Quality Interventions: An Innovative Platform for Oncology Practice Collaboration

Joshua Nubla, PharmD
Neal Dave, PharmD
Michael Reff, RPh, MBA

Care for patients in the oncology setting is extremely diverse and complex. Management of the many distinct oral oncolytic regimens through pharmacy dispensing platforms in clinical practice can leave gaps within the healthcare system that should be addressed…

Innovative Approaches to Dispensing Oral Oncolytics in Community Oncology

Michael Reff, RPh, MBA

This is the first part of a 3-part series on improving patient care through innovative approaches to dispensing oral oncolytic drugs in the community practice setting. A little more than 2 years ago, a group of like-minded pharmacists from across New York State got together to create an initial framework that would help oncology practices deliver optimal care to their patients who are receiving oral oncolytics…

Passionate Financial
Support - An
Antidote for
Financial Toxicity

Michael Reff, RPh, MBA
Hannah Peaboday, CPHT
Deborah Walters, RN, OCN

Financial toxicity has become an urgent issue in the field of oncology due to the ever-growing number of patients having difficulty paying for their complex oncolytic treatments. This financial toxicity can lead to a decrease in adherence to cancer therapy…

Physician Dispensing Adding Value to Patients and the Practice

Michael Reff, RPh, MBA

While oral oncolytics are serious medications prescribed to help patients with serious ailments, there can be misconceptions that medicines in “pill” form do not require the same level of diligence from patients and providers. Instead, patients and providers should fully understand and appreciate the risks and benefits before an oral oncolytic is prescribed…